Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

New England Journal of Medicine

Volumn 338, Issue 14, 1998, Pages 962-968

  Hansen, John A ^a,b   Gooley, Theodore A ^a   Martin, Paul J ^a   Appelbaum, Frederick ^a   Chauncey, Thomas R ^a   Clift, Reginald A ^a   Petersdorf, Effie W ^a   Radich, Jerald ^a   Sanders, Jean E ^a   Storb, Rainer F ^a   Sullivan, Keith M ^a   Anasetti, Claudio ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PHILADELPHIA 1 CHROMOSOME; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS;

EID: 0008947293     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199804023381405     Document Type: Article

References (38)

1. Thomas ED, Clift RA, Fefer A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986;104: 155-63.
2. Goldman JM, Apperley JF, Jones L, et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986;314:202-7.
3. McCullough J, Hansen J, Perkins H, Stroncek D, Bartsch G. The National Marrow Donor Program: how it works, accomplishments to date. Oncology 1989;3:63-74.
4. Beatty PG, Ash R, Hows JM, McGlavc PB. The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of tour marrow transplant centers. Bone Marrow Transplant 1989;4:287-90.
5. McGlave PB, Beatty P, Ash R, Hows JM. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood 1990;75:1728-32. [Erratum, Blood 1990;76:654.]
6. Mackinnon S, Hows JM, Goldman JM, et al. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors. Exp Hematol 1990;18:421-5.
7. McGlave P, Bartsch G, Anasetti C, et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993;81:543-50.
8. Marks DI, Cullis JO, Ward KN, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first 2 years. Ann Intern Med 1993;119:207-14.
9. Spencer A, Szydlo RM, Brookes PA, et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995;86:3590-7
10. Hathaway ML, Foard ED. Heights and weights of adults in the U.S. Home Economics Research Report no. 10. Washington, D.C.: Department of Agriculture, 1960:111.
11. Petersdorf EW, Longton GM, Anasctti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995;86:1606-13.
12. Hansen JA, Mickelson EM, Choo SY, et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM, eds. Manual of clinical laboratory immunology. 4th ed. Washington, D.C.: American Society for Microbiology, 1992:850-66.
13. Mickelson EM, Guthrie LA, Etzioni R, Anasetti C, Martin PJ, Hansen JA. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors. Tissue Antigens 1994;44:83-92.
14. Mickelson EM, Longton G, Anasetti C, et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996;47:27-36.
15. Beatty PG, Hansen JA, Longton GM, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991;51:443-7
16. Anasetti C, Petersdorf EW, Martin PJ, Hansen JA. Marrow transplantation from unrelated volunteer donors. In: Buckner CD, Clift RA, eds. Technical and biological components of marrow transplantation. Cancer treatment and research no. 76. Boston: Kluwer Academic, 1995:137-68.
17. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone tor prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314:729-35.
18. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Aim Intern Med 1993;118:173-8.
19. Goodrich JM, Boeckh M, Bowden R. Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clin Infect Dis 1994;19:287-98.
20. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation a prospective, randomized, double-blind study. J Infect Dis 1995;171: 1545-52.
21. Blazar BR, Orr HT, Arthur DC, Kersey JH, Fillipovich AH. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 1985;66:1436-44.
22. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989;74:2220-6.
23. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
24. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-9.
25. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 1993;83:602-7.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
27. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036-43.
28. Petersdorf EW, Longton GM, Anasetti C, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997;89:1818-23.
29. Nash RA, Pepe MS, Storb R, et al. Acute graft-versvis-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992;80:1838-45.
30. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985;313:765-71.
31. Anasetti C, Hansen JA. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Transfus Sci 1994;15:221-30.
32. Goldman JM, Szydlo R, Horowitz MM, et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993;82:2235-8.
33. Buckner CD, Clift RA. Timing of allogeneic marrow transplants for patients with chronic myeloid leukemia. Bone Marrow Transplant 1995;15: Suppl 1:S203-S206.
34. A in chronic myelogenous leukemia. N Engl J Med 1986;314:1065-9.
35. Hehlmann R, Heimpel H, Hasfbrd J, et al. Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994;84:4064-77
36. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994;330:820-5.
37. Allan NC, Richards SM, Shepherd PC. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukemia: improved survival irrespective of cytogenetic response. Lancet 1995;345:1392-7
38. Lee SJ, Kuntz KM, Morowitz MM, et al. Unrelated donor bone marrow transplantation for chronic myeloid leukemia: a decision analysis. Ann Intern Med 1997;127:1080-8.